Myocardial Infarction
Reference76 articles.
1. Adgey AAJ, Geddes JS, Mulholland HC, et al. Incidence, significance, and management of early brady-arrhythmia complicating acute myocardial infarction. Lancet. 1968;2:1097.
2. Ambrosioni E, Borghi C, Magnani B, for the Survival of Myocardial Infarction Long-Term Evaluation (SMILE) Study Investigators, et al. The effect of the angiotensin-converting enzyme inhibitor zofen-opril on mortality and morbidity after anterior myocardial infarction. N Engl J Med. 1995;332:80.
3. Antman M, Cohen M, Bernink P, et al. The TIMI risk score for unstable angina/non–ST elevation MIA method for prognostication and therapeutic decision making. JAMA. 2000;284(7):835–42.
4. ASSENT-2 Investigators. Assessment of the safety and efficacy of a new thrombolytic: single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: The ASSENT-2 double-blind randomized trial. Lancet. 1999;354:716.
5. Beta-blocker heart attack study group (BHAT). The beta blocker heart attack trial. JAMA. 1981;246:2073.